Status:
TERMINATED
Safety and Effectiveness of tPA in Intra-abdominal Abscesses
Lead Sponsor:
University Health Network, Toronto
Conditions:
Abscess
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
To determine if instillation of tissue plasminogen activator into a percutaneously drained intra-abdominal abscess cavity results in faster resolution of the abscess compared to normal standard of car...
Detailed Description
On day 0 Subjects will have Tissue Plasminogen Activator injected into a drainage tube and allowed to dwell in the intra-abdominal abscess for one hour before allowing it to drain by gravity. This wil...
Eligibility Criteria
Inclusion
- Intrabdominal abscess
Exclusion
- Hypersensitivity to tPA
- Recent stroke
- Uncontrolled htn
- Recent major hemorrhage
- Pregnancy
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00417768
Start Date
July 1 2005
End Date
November 1 2013
Last Update
January 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada